ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease symptoms in this underserved patient populationADAPT SERON, ...
The 2 per cent (DR) for pensioners, which similarly increases from 58 per cent to 60 per cent. The Dearness Allowance is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results